The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2-) breast cancer: When might multigene assays be of value?
暂无分享，去创建一个
P. Neven | D. Rea | R. Rouzier | M. Aapro | E. Mamounas | A. Petrovsky | C. Thomssen | C. Markopoulos | V. Smit | B. Linderholm | Miguel Martín | L. Landherr | C. Svedman | M. de Laurentiis | J. E. Bargalló Rocha | Roberto J. Elizalde | Daniel Schneider